The co-expression of a PD-1-CD28 fusion protein antagonized PD-L1-mediated suppression of TRuC + PD-1-CD28 T cells as shown in enhanced cytokine release and improved anti-tumor activity in PD-L1 + tumor models. Here, PDCD1 is linked to neoplasm.